Forvis Mazars sponsored FT Live: Global Pharma and Biotech Summit 2025

Panel spotlight: Global health security – Steering progress on pandemic readiness

We’re proud that Nigel Layton, Global Head of Life Sciences at Forvis Mazars, spoke at this year’s summit.

Agenda

Nigel joined senior leaders from Pfizer and Ecolab to explore how the biopharma sector could prepare for future pandemic threats. With the WHO Pandemic Agreement aiming to strengthen global health security, the panel addressed the complex challenges facing the industry, including:

• What progress has been made in building global systems for early detection and response?
• What incentives will there be to maintain investment in R&D for pandemic threats?
• How can public-private partnerships be structured to support innovation while ensuring equitable access?
• How can approvals be managed globally to prevent bottlenecks while maintaining safety and efficacy standards?

Speakers

• Nigel Layton, Global Head of Life Sciences, Forvis Mazars
• John McGinley, UK Managing Director and Country President, Pfizer
• Meeta Gulyani, General Manager of Bioprocessing and Head of Life Science Strategy, Ecolab
• Roy Anderson, Professor of Infectious Diseases, Imperial College London

Speak to our life sciences experts

Get in touch